Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for perioperative brain protection in cardiac surgery with cardiopulmonary bypass
ChiCTR2300069914Phase 4Not yet recruiting
- Sponsor
- Central Hospital Affiliated to Shandong First Medical University
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in traumatic brain injury (TBI) comparing Esketamine group with Placebo group (2 arms). Primary endpoints: Serum neuron-specific enolase (NSE) and Serum S100b protein. Planned start Apr 2023; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on ChiCTR2300069914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300069914.